Evonik appoints Yann d’Herve as new head of Health Care business line

Evonik appoints Yann d’Herve as new head of Health Care business line

Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1

  • By ICN Bureau | July 03, 2024

Yann d’Hervé, previously Head of the Care Solutions business line in Evonik’s Nutrition & Care division, will lead the Health Care business line as of July 1.

Yann d’Hervé holds an MSc in Chemistry and an MBA. He joined the former REXIM SAS (France) in 1996, where he worked in a number of different roles. REXIM is now part of the Health Care business line. In 2004, he moved to the U.S. to join what is Oil Additives business line, working as a business analyst and subsequently as Global Business Director for Wax Modifiers. In 2011, the Health Care business line was formed and d’Hervé became Vice President, Sales & Services Americas. In 2015, he assumed the role as Vice President, Global Sales & Services before moving to Germany to lead the Care Solutions business line in 2020.

Yann has extensive experience in manufacturing, finance, marketing, application technology, sales and general management. He has managed international organizations, while being responsible for strategic alliances with key partners. Customer satisfaction and joint value creation are two cornerstones in d’Hervé’s approach to business.

Evonik Health Care partners with the world’s pharmaceutical, medical and nutritional companies to transform complexity into value. With a broad and versatile portfolio of high-quality ingredients, delivery systems and contract services, Evonik Health Care generates distinctive outcomes that advance health and well-being.

Register Now to Attend Navigating the Path to Net-zero in the Chemicals Industry on Friday, 26 July 2024

Other Related stories